Comparability study between downstream methodologies using physicochemical characteristics of hyperimmune serum for human use
DOI:
https://doi.org/10.34119/bjhrv6n3-059Keywords:
drug industry, quality control, orphan drug production, immunoglobulin fragmentsAbstract
This study compared two downstream methodologies of antivenom production and statistically evaluated the results of quality control between batches of Antiloxoscelic Serum (approved or not) of these methods. The methodologies present significant downstream differences related to the quality control results. The document analysis and statistical evaluation of the results were obtained using a control chart. All batches showed physical-chemical results within the specification limits, but not all downstream B results were within the process control limits. In all quantitative results analyzed (total protein, non-protein nitrogen, phenol, total solids, pH, chloride), it was possible to verify that the downstream B samples did not meet the process control criteria established by the control chart. The conclusion is that method B is outside the control of the stipulated production process.
References
Al-Abdulla, I., Casewell, N. R., & Landon, J. (2014). Single-reagent one-step procedures for the purification of ovine IgG, F(ab′)2 and Fab antivenoms by caprylic acid. Journal of Immunological Methods, 402(1–2), 15–22. https://doi.org/10.1016/j.jim.2013.11.001
Brasil. (1996). Portaria n°174 de 11 de novembro de 1996. Normas Técnicas de Produção e Controle de Qualidade dos Soros Antiofídicos, Antitóxicos e Anti-rábicos. Diário Oficial Da República Federativa Do Brasil, 220(12 nov. 1996), p.23503.
Brasil. (2019). In ANVISA (Ed.), Farmacopeia Brasileira: Vol. II (6th ed., Issues PB030-00, PB037-00). Ministério da Saúde/Agência Nacional de Vigilância Sanitária.
Caricati, C. P., Oliveira-Nascimento, L., Yoshida, J. T., Stephano, M. A., Caricati, A. T. P., & Raw, I. (2013). Safety of snake antivenom immunoglobulins: Efficacy of viral inactivation in a complete downstream process. Biotechnology Progress, 29(4), 972–979. https://doi.org/10.1002/btpr.1758
Chulasugandha, P. (2003). Snake antivenoms: Heterologous and polyclonal antisera. Journal of Toxicology - Toxin Reviews, 22(1), 1–14. https://doi.org/10.1081/TXR-120019561
European Directorate for the Quality of Medicines & Healthcare. Council of Europe. (2021). General monographs - immunosera for human use, animal 0084 (issue 11.0, pp. 929–932). EDQM.
European Directorate for the Quality of Medicines & Healthcare, C. of E. (2016). Methods of analysis - electrophoresis. In European Pharmacopeia 11.0 (Issue 11.0, pp. 57–63). EDQM.
García, M., Monge, M., León, G., Lizano, S., Segura, E., Solano, G., Rojas, G., & Gutiérrez, J. M. (2002). Effect of preservatives on IgG aggregation, complement-activating effect and hypotensive activity of horse polyvalent antivenom used in snakebite envenomation. Biologicals, 30(2), 143–151. https://doi.org/10.1006/biol.2002.0329
Gutiérrez, J. M. (2019). Global availability of antivenoms: The relevance of public manufacturing laboratories. Toxins, 11(1), 1–13. https://doi.org/10.3390/toxins11010005
Gutiérrez, J. M., León, G., Lomonte, B., & Angulo, Y. (2011). Antivenoms for snakebite envenomings. Inflammation and Allergy - Drug Targets, 10(5), 369–380. https://doi.org/10.2174/187152811797200669
Hassan, H. S., Najam, A., Parveen, G., Ali, H., Channa, R. A., & Adeel, S. S. (2020). An optimized method of IgG’s precipitation with ammonium sulphate from hyper immune horse plasma for snake anti venom production. International Journal of Molecular Biology: Open Access, 5(4), 166–169. https://doi.org/10.15406/ijmboa.2020.05.00144
INCQS, I. N. de C. de Q. em S.-. (2015). Protocolo de determinação da massa molecular e homogeneidade de Proteínas por eletroforese descontínua em gel de poliacrilamida para soros hiperimunes.
Isbister, G. K., & Silva, A. (2018). Addressing the global challenge of snake envenoming. The Lancet, 392(10148), 619–620. https://doi.org/10.1016/S0140-6736(18)31328-X
Knudsen, C., Ledsgaard, L., Dehli, R. I., Ahmadi, S., Sørensen, C. V., & Laustsen, A. H. (2019). Engineering and design considerations for next-generation snakebite antivenoms. Toxicon, 167(May), 67–75. https://doi.org/10.1016/j.toxicon.2019.06.005
Kurtović, T., Balija, M. L., Brgles, M., Sviben, D., Tunjić, M., Cajner, H., Marchetti-Deschmann, M., Allmaier, G., & Halassy, B. (2019). Refinement strategy for antivenom preparation of high yield and quality. PLoS Neglected Tropical Diseases, 13(6), 1–23. https://doi.org/10.1371/journal.pntd.0007431
Kurtović, T., Brgles, M., Balija, M. L., Steinberger, S., Sviben, D., Marchetti-Deschmann, M., & Halassy, B. (2020). Streamlined downstream process for efficient and sustainable (Fab’)2 antivenom preparation. Journal of Venomous Animals and Toxins Including Tropical Diseases, 26(July), 1–12. https://doi.org/10.1590/1678-9199-JVATITD-2020-0025
Laustsen, A. H., & Dorrestijn, N. (2018). Integrating engineering, manufacturing, and regulatory considerations in the development of novel antivenoms. Toxins, 10(8). https://doi.org/10.3390/toxins10080309
Lavonas, E. (2012). Antivenoms for Snakebite: Design, Function, and Controversies. Current Pharmaceutical Biotechnology, 13(10), 1980–1986. https://doi.org/10.2174/138920112802273227
León, G., Herrera, M., Segura, Á., Villalta, M., Vargas, M., & Gutiérrez, J. M. (2013). Pathogenic mechanisms underlying adverse reactions induced by intravenous administration of snake antivenoms. Toxicon, 76, 63–76. https://doi.org/10.1016/j.toxicon.2013.09.010
León, G., Monge, M., Rojas, E., Lomonte, B., & Gutiérrez, J. M. (2001). Comparison between IgG and F(ab′)2 polyvalent antivenoms: Neutralization of systemic effects induced by Bothrops asper venom in mice, extravasation to muscle tissue, and potential for induction of adverse reactions. Toxicon, 39(6), 793–801. https://doi.org/10.1016/S0041-0101(00)00209-9
León, G., Segura, Á., Gómez, A., Hernandez, A., Navarro, D., & Villalta, M. (2016). Industrial Production and quality control of snake antivenoms. In P. Gopalakrishnakone & J. J. Calvete (Eds.), Toxinology. Venom Genomics and Proteomics (pp. 425–448). Springer Science Business Media Dordrecht. https://doi.org/10.1007/978-94-007-6649-5
León, G., Vargas, M., Segura, Á., Herrera, M., Villalta, M., Sánchez, A., Solano, G., Gómez, A., Sánchez, M., Estrada, R., & Gutiérrez, J. M. (2018a). Current technology for the industrial manufacture of snake antivenoms. Toxicon, 151(May), 63–73. https://doi.org/10.1016/j.toxicon.2018.06.084
León, G., Vargas, M., Segura, Á., Herrera, M., Villalta, M., Sánchez, A., Solano, G., Gómez, A., Sánchez, M., Estrada, R., & Gutiérrez, J. M. (2018b). Current technology for the industrial manufacture of snake antivenoms. Toxicon, 151, 63–73. https://doi.org/10.1016/j.toxicon.2018.06.084
Lima, A. A. N., Lima, J. R., Silva, J. L., Alencar, J. R. B., Soares-Sobrinho, J. L., Lima, L. G., & Rolim-Neto, P. J. (2006). Aplicação do controle estatístico de processo na indústria farmacêutica. Revista de Ciencias Farmaceuticas Basica e Aplicada, 27(3), 177–187.
Lukačević, S. M., Kurtović, T., Balija, M. L., Brgles, M., Steinberger, S., Marchetti-Deschmann, M., & Halassy, B. (2020). Quality-Related Properties of Equine immunoglobulins purified by different approaches. Toxins, 12(12), 798–817.
Monteiro, C., Crepaldi, R. M. C., Avelar, A. F. M., Peterlini, M. A. S., & Pedreira, M. D. L. G. (2012). Potencial hidrogeniônico de soluções de antibióticos submetidas a condições ambientais: Ensaio preliminar. Revista Da Escola de Enfermagem, 46(2), 311–319. https://doi.org/10.1590/S0080-62342012000200007
Morais, V. M., & Massaldi, H. (2009). Snake antivenoms: adverse reactions and production technology. Journal of Venomous Animals and Toxins Including Tropical Diseases, 15(1), 2–18.
Page, M., & Thorpe, R. (2003). Purification of IgG by Precipitation with Sodium Sulfate or Ammonium Sulfate. Protein Protocols Handbook, The, 983–984. https://doi.org/10.1385/1-59259-169-8:983
Raweerith, R., & Ratanabanangkoon, K. (2003). Fractionation of equine antivenom using caprylic acid precipitation in combination with cationic ion-exchange chromatography. Journal of Immunological Methods, 282(1–2), 63–72. https://doi.org/10.1016/j.jim.2003.07.014
Rojas, G., Vargas, M., Robles, A., & Gutierrez, jose maria. (1993). Turbidity of hyperimmune equine antivenom : the role of phenol and serum lipoproteins. Toxicon, 31(1), 61–66.
Salomão, M. da G. (2018). Epidemiologia dos acidentes por animais peçonhentos e a distribuição de soros: estado de arte e a situação mundial. Revista de Salud Pública, 20(4), 523–529. https://doi.org/10.15446/rsap.v20n4.70432
Santana, L. A., Vicari, M. V., Motta, O. J. R. da, Novelli, M. M., Montenegro, S. S. P., Pereira, S. de O., Machado, G. R., Sant’Ana, J. L. P., & Silva, E. da. (2020). Arachnidism in Brazil / Aracnidismo no Brasil. Brazilian Journal of Health Review, 3(5), 12859–12872. https://doi.org/10.34119/bjhrv3n5-120
Segura, Á., Herrera, M., Villalta, M., Vargas, M., Gutiérrez, J. M., & León, G. (2013). Assessment of snake antivenom purity by comparing physicochemical and immunochemical methods. Biologicals, 41(2), 93–97. https://doi.org/10.1016/j.biologicals.2012.11.001
Segura, Á., Herrera, M., González, E., Vargas, M., Solano, G., Gutiérrez, J. M., & León, G. (2009). Stability of equine IgG antivenoms obtained by caprylic acid precipitation: Towards a liquid formulation stable at tropical room temperature. Toxicon, 53(6), 609–615. https://doi.org/10.1016/j.toxicon.2009.01.012
Shah, S., Shridhar, P., & Gohil, D. (2010). Control chart : A statistical process control tool in pharmacy. Asian Journal of Pharmaceutics, 4(3), 184–192. https://doi.org/10.4103/0973-8398.72116
Silva, R. S. da, Silva, E. H. O. da, Abreu, C. B., Pessoa, D. L., Teixeira, F. F. N., & Silva, F. O. (2020). Análise Epidemiológica de Acidentes por Animais Peçonhentos no Estado do Amazonas no Período de 2015 a 2018/ Epidemiological Analysis of Accidents by Venomous Animals in the State of Amazonas in the Period from 2015 to 2018. Brazilian Journal of Health Review, 3(6), 18359–18375. https://doi.org/10.34119/bjhrv3n6-233
Werkema, M. C. C. (1995). Ferramentas Estatísticas Básicas para o Gerenciamento de Processos. Fundação Cristiano Ottoni.
Who Expert Committee on Biological Standardization. (2017). Guidelines for the production, control and regulation of snake antivenom immunoglobulins. World Health Organization Technical Report Series, Anexx 5(1004), 192.
World Health Organization. (2019). List of antivenoms. https://apps.who.int/bloodproducts/ snakeantivenoms/database/
Zurbano, B. N., Tavarone, E., Viacava, B. G., Dokmetjian, J. C., Cascone, O., & Fingermann, M. (2020). Critical aspects on traditional antivenom production processes and their optimization by factorial analysis. Biologicals, 68(May), 65–73. https://doi.org/10.1016/j.biologicals.2020.08.005
